Insights

Strategic Business Shift Galapagos is actively evaluating its portfolio, with plans to wind down its cell therapy business following a strategic review, indicating an opportunity to provide tailored solutions for their ongoing transformation and potential partnerships in other therapeutic areas.

Innovative Therapy Development With recent presentations on advanced therapies like GLPG5101 and GLPG3667, Galapagos emphasizes its focus on high-impact biologics and targeted treatments, opening avenues for technology providers and service partners in clinical research and data analytics.

Geographic Expansion The company's operations span the U.S., Europe, and Asia, highlighting an opportunity to offer regional regulatory, logistics, or commercialization solutions to support their global clinical trials and market expansion efforts.

Financial Growth Potential With revenue estimates between 100 million and 250 million dollars and ongoing assets in cutting-edge therapies, Galapagos represents a promising client for investment in research tools, bioprocessing technologies, and strategic consulting to accelerate growth.

Technology Ecosystem Utilizing cloud services like AWS, SAP, and VMware, Galapagos demonstrates a mature digital infrastructure, providing opportunities for enterprise software providers, cybersecurity solutions, and data integration services to enhance their operational efficiency.

Galapagos Tech Stack

Galapagos uses 8 technology products and services including Amazon Web Services, SAP, Apple iCloud Mail, and more. Explore Galapagos's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • SAP
    Customer Relationship Management
  • Apple iCloud Mail
    Email
  • IQVIA
    Health Platform
  • Microsoft
    Miscellaneous
  • Cloudflare Bot Management
    Security
  • VMware
    Virtualisation Software
  • Apache
    Web Servers

Media & News

Galapagos's Email Address Formats

Galapagos uses at least 1 format(s):
Galapagos Email FormatsExamplePercentage
First.Last@glpg.comJohn.Doe@glpg.com
78%
Last_First@glpg.comDoe_John@glpg.com
12%
FirstLast@glpg.comJohnDoe@glpg.com
5%
First.MiddleLast@glpg.comJohn.MichaelDoe@glpg.com
5%

Frequently Asked Questions

Where is Galapagos's headquarters located?

Minus sign iconPlus sign icon
Galapagos's main headquarters is located at Generaal De Wittelaan L11 A3, Mechelen, Belgium 2800, BE. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Galapagos's stock symbol?

Minus sign iconPlus sign icon
Galapagos is a publicly traded company; the company's stock symbol is GLPG.

What is Galapagos's official website and social media links?

Minus sign iconPlus sign icon
Galapagos's official website is glpg.com and has social profiles on LinkedIn.

What is Galapagos's SIC code NAICS code?

Minus sign iconPlus sign icon
Galapagos's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Galapagos have currently?

Minus sign iconPlus sign icon
As of October 2025, Galapagos has approximately 902 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer: P. S.Chief Human Resources Officer: A. M.Vice President Of Global Product Quality And Analytical Sciences, Cell Therapies: C. D.. Explore Galapagos's employee directory with LeadIQ.

What industry does Galapagos belong to?

Minus sign iconPlus sign icon
Galapagos operates in the Biotechnology Research industry.

What technology does Galapagos use?

Minus sign iconPlus sign icon
Galapagos's tech stack includes Amazon Web ServicesSAPApple iCloud MailIQVIAMicrosoftCloudflare Bot ManagementVMwareApache.

What is Galapagos's email format?

Minus sign iconPlus sign icon
Galapagos's email format typically follows the pattern of First.Last@glpg.com. Find more Galapagos email formats with LeadIQ.

When was Galapagos founded?

Minus sign iconPlus sign icon
Galapagos was founded in 1999.
Galapagos

Galapagos

Biotechnology ResearchBelgium501-1000 Employees

We are a biotechnology company with operations in the U.S., Europe and Asia, dedicated to developing transformational medicines for more years of life and quality of life. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class therapies. With capabilities from lab to patient, including an innovative decentralized cell therapy manufacturing platform, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.

Section iconCompany Overview

Headquarters
Generaal De Wittelaan L11 A3, Mechelen, Belgium 2800, BE
Website
glpg.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GLPG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
501-1000

Section iconFunding & Financials

  • $100M$250M

    Galapagos's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Galapagos's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.